Elbow Osteoarthritis
Conditions
Keywords
elbow arthroscopy, DASH, elbow locking, elbow osteoarthritis
Brief summary
The study is a prospective case controlled clinical trial. The purpose of the study is to investigate the effect of elbow arthroscopy in the treatment for osteoarthritis of the elbow when compared to conservative treatment.
Detailed description
Patients will be recruited at departments of hand surgery and orthopedic surgery outpatient clinics. The control group will be patients to whom the conservative treatment continues. Patients who meet the inclusion criteria will be asked to participate and sign the informed consent. Therefore the investigators have two treatment groups: group 1 who receives an elbow joint debridement arthroscopically without physiotherapy and group 2 who receives only conservative treatment with physiotherapy.
Interventions
PROCEDUREElbow arthroscopy
Arthroscopic debridement, osteophyte excision, loose body extirpation is carried on to patients.
OTHERConservative treatment
Physiotherapy protocol is introduced to patients.
Sponsors
Central Finland Hospital District
Tampere University Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Symptomatic post-traumatic or primary osteoarthritis - mechanical locking and/or decreased range of motion ( \>30°) * Radiographic evidence of at least mild primary or post-traumatic osteoarthritis according to Broberg - Morrey classification symptoms lasting at least 6 months * Patients willingness to participate the study * All patients 18-80 ages
Exclusion criteria
* Patients with previous severe soft tissue trauma at elbow region ( crush, burns etc - the elbow joint problems are not joint specific) * Patients with crystal arthropathy or inflammatory arthritis * Patient refuses to participate the study * Patients with dementia or are institutionalized * Patients with severe substance addiction * Patient does not understand written and spoken guidance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quick DASH score | 24 Months |
Secondary
| Measure | Time frame |
|---|---|
| VAS score | 24 Months |
| Range of motion | 24 Months |
Countries
Finland
Contacts
Primary ContactMargit Karelson, MD
Backup ContactAntti Launonen, MD, PhD
Outcome results
None listed